September 16, 2025
Last updated: May 23, 2026 · By Compliance Carl, Senior Compliance Editor
On April 27, 2026 — one day before the federal Schedule III rescheduling of state-licensed medical marijuana took effect — the Transportation Security Administration quietly updated its Medical Marijuana page on the What Can I Bring? tool. The carry-on and checked-bag entries now read Yes (Special Instructions). The page's old paragraphs declaring marijuana federally illegal are gone. The standing officer instruction now refers to illegal drugs rather than marijuana or other illegal drugs.
The page does not, anywhere, explain what the special instructions are. There is no quantity limit. There is no documentation requirement. There is no list of qualifying states or product types. As of this writing, the page sits there with a green Yes and a label that links to nothing.
That is the news, and it is most of what travelers actually need to understand. The rest — what counts as compliant, what an Atlanta airport police officer will do when she sees a vape pen in your bag, whether your hemp seltzer is about to be reclassified out of existence on November 12 — is the part this guide is here to cover.
The textual change to the TSA page is real, and the timing is not a coincidence. Acting Attorney General Todd Blanche signed the DOJ rescheduling order on April 22, 2026; the DEA's corresponding Federal Register notice published on April 28; the TSA page update landed in between. DOJ's announcement describes the change as placing two specific categories — FDA-approved drug products containing marijuana, and marijuana subject to a qualifying state-issued medical license — in Schedule III. Everything else stays in Schedule I.
What did not change, and the part that is getting badly misreported, is TSA's actual enforcement posture. A TSA spokesperson told Snopes in early May that the agency's policy on medical marijuana has not changed, and that the screening protocol — which has technically permitted medical cannabis meeting federal requirements since 2019 — is the same protocol that was in force the week before the April rescheduling. GBH News reported on May 19, 2026 that the union representing New England TSA workers had not been briefed on the policy implications of the change as of mid-May. Frontline screeners are reading the website like everyone else.
The honest summary: a piece of TSA website copy now matches a piece of federal scheduling law. What that means in operational terms, at any given checkpoint on any given day, is up to the screener and to the local airport police who get called if cannabis is found.
The April rescheduling moves only two things to Schedule III. Everything outside those two categories is still Schedule I, and for air travel that distinction is the whole game.
The first category is FDA-approved cannabis-derived pharmaceuticals. The four currently approved are Epidiolex (cannabidiol oral solution, approved for refractory pediatric epilepsy and tuberous sclerosis complex), Marinol and Syndros (synthetic dronabinol), and Cesamet (nabilone). These have always been the cleanest air-travel scenario for any cannabis-derived product: they ship in original pharmacy packaging with a prescription label and your name on it, and TSA's general medication carry-on guidance applies. The rescheduling does not change how they are handled at the checkpoint — but it does mean that if a screener pulls one out of your bag and asks, the answer is now Schedule III prescription rather than Schedule III prescription that contains a Schedule I substance, which was the awkward prior framing.
The second category is the more consequential one. Marijuana that is manufactured, distributed, or dispensed under a qualifying state-issued license, for medical purposes only, is now Schedule III. The phrase for medical purposes only is doing real structural work in the order. A state license that authorizes both medical and adult-use activity does not, on the face of the order, qualify the medical activity for Schedule III. DEA has signaled it will look at operational separation — segregated inventory, separate registration, customer-facing program — not the paper of the license alone.
What this means for a traveler: a Florida medical marijuana patient with a state card and a state-licensed product is, post-April 28, carrying a Schedule III product through the checkpoint. A New Jersey adult-use customer with a recreationally purchased product is still carrying a Schedule I product, even though the flower may have come from the same building. The TSA page's green Yes applies to the first traveler and not to the second. For the deeper operator-side picture on this split, see our two-tier federal cannabis market explainer.
The largest single category of cannabis-adjacent product that travelers actually carry through TSA in 2026 is not marijuana flower. It is hemp-derived CBD oils, tinctures, and Delta-9 THC beverages — the Cann, Wynk, Nowadays, and BRĒZ category — sold over the counter at gas stations and grocery stores in states that allow them.
Through November 11, 2026, these products are governed by the 2018 Farm Bill's hemp definition: cannabis with no more than 0.3 percent Delta-9 THC by dry weight. A standard 12-ounce Cann clears that threshold because the calculation is by dry weight of the source cannabis, not by Delta-9 milligrams per finished serving. TSA's screening posture on Farm Bill–compliant hemp products is essentially nonexistent — agents do not screen for it, are not equipped to test for THC percentage on the spot, and have no protocol that singles out hemp drinks from any other beverage. The only TSA-level issue is the standard 3.4-ounce liquid rule for carry-on, which is what catches most hemp beverage travelers. Larger containers go in checked bags or get left behind.
If you are flying with a hemp Delta-9 drink in 2026, the practical risk is not TSA. It is destination-state and airport-of-arrival law. We have covered the brand-specific picture and current state filters in detail in our 2026 THC drinks guide.
The hemp-product picture changes hard on November 12, 2026. That is the effective date of Section 781 of H.R. 5371, the November 2025 continuing resolution that quietly rewrote the federal hemp definition. Arnold & Porter's December 2025 analysis walks through the mechanics.
The new federal definition replaces the 0.3-percent-Delta-9-by-dry-weight test with a 0.4-milligram-total-THC-per-container cap. Total THC includes Delta-9, THCA, and any other cannabinoid the Secretary of HHS designates as having similar effects. Most existing hemp gummy and beverage formulations — which routinely contain 2 to 10 milligrams of Delta-9 per serving and 10 to 50 milligrams per container — fall on the wrong side of the new line. Industry groups estimate roughly 95 percent of current hemp-derived cannabinoid products will be federally non-compliant on the morning of November 12.
For a traveler in mid-November, the question of whether a hemp seltzer is federally legal will turn on the per-container milligram math, not the dry-weight percentage. Products purchased before the effective date do not become contraband retroactively, but they are also not protected by some grandfather clause, and the carrier and airport-police posture on November 13 is anyone's guess. The smart move for anyone flying with hemp beverages or edibles in the fall of 2026 is to assume the rules tighten and to leave anything you would not want confiscated at home. Operators making forward decisions on shipping and inventory should see our 2026 carrier-policy tightening analysis.
For Farm Bill–compliant hemp products, the documentation that most matters is the product's Certificate of Analysis. Carry the batch-specific COA — paper or phone — that matches the lot number on the label. The COA should clearly show Delta-9 THC at or below 0.3 percent by dry weight and identify hemp as the source. TSA agents do not read COAs as a matter of course, but airport police called in to evaluate a product often will, and a clean COA on the spot dramatically shortens the conversation.
For state-licensed medical cannabis post-April 28, the documentation that matters is your state medical card paired with state-licensed product packaging. The product should be in its original child-resistant dispensary container with the dispensary label, batch identifier, and patient name intact. A dispensary receipt with the patient name is a useful add-on. None of this is required by TSA — TSA does not gate-check medical cards — but airport police in states that recognize the rescheduling will look at exactly these documents when they decide whether to call it federally compliant or not.
Original packaging is not a polite suggestion. Removing edibles from dispensary packaging to put them in a pill organizer or a sandwich bag converts a compliant Schedule III product into an unknown brown substance, and the screener has no way to distinguish the two. Same with tinctures decanted into travel bottles. Same with flower in a smell-proof pouch.
The TSA page change does not preempt state law. State and local police enforce the state criminal code at the airport, and a federal Schedule III designation does not create a federal preemption that protects a traveler from arrest under, say, the Georgia Controlled Substances Act. The April rescheduling did not change the calculus on the state side at all.
In broad strokes, the airport-by-airport picture in 2026 looks like this. Los Angeles International (LAX) operates under a written Los Angeles Airport Police Division policy that does not arrest adults 21 and over carrying compliant amounts of cannabis through screening; the policy long predates the rescheduling. San Francisco, Oakland, Seattle-Tacoma, Denver (with a quirk — DEN has its own airport-specific cannabis ban inside terminal property, separate from Colorado state law), Las Vegas, Phoenix, Boston, Chicago O'Hare and Midway (the Chicago airports have amnesty boxes at security), New York LGA and JFK, and Portland behave broadly the way LAX does: not actively looking, not arresting compliant adults.
The other side of the map is the part to take seriously. Atlanta-Hartsfield, Dallas-Fort Worth, Houston Intercontinental, Miami International, Orlando, Charlotte-Douglas, Nashville, Birmingham, Jackson (Mississippi), Oklahoma City, and Memphis route cannabis discoveries to airport police, and those airport police operate under state codes that treat possession as a criminal offense regardless of how the traveler obtained the product. A New Jersey patient with a state card and a New Jersey-compliant THCA product who lands in Atlanta has, on landing, the same legal status as anyone else in Georgia carrying cannabis. The patient card does not travel.
The federal medical-marijuana program does not, despite years of legislative attempts, include any out-of-state patient reciprocity for transport. A handful of state programs allow visiting patients to purchase locally on a temporary card. None of them allows a visiting patient to bring product across the state line.
Hemp and cannabis vapes are governed by FAA hazardous materials rules, not TSA cannabis posture. The FAA's PackSafe entry on e-cigarettes requires that all vape devices and spare lithium batteries travel in carry-on, never checked, with batteries protected from short-circuit (in the device, in a case, or with the terminals taped). The cannabinoid content is downstream of the battery question; the battery question is what gets a checked bag pulled. Hemp vape shipping has its own separate world — the PACT Act effectively bans direct-to-consumer hemp vape shipping by USPS, UPS, FedEx, and DHL, which we have covered in our PACT Act hemp vape analysis.
Edibles — gummies, chocolates, brownies, mints — are solids and do not trigger the liquid rule. The TSA-level posture on hemp-derived edibles is, like beverages, essentially nonexistent through November 11. After November 12, the milligram math determines federal status. We break down the form-by-form picture in the edibles-on-a-plane guide.
Tinctures and oils are liquids and are bound by the 3.4-ounce / 100-milliliter carry-on limit. A 1-ounce CBD dropper bottle is fine in carry-on; a 4-ounce bottle is not, regardless of cannabinoid content. Pharmacy-labeled prescription liquids in excess of 3.4 ounces are exempt from the liquid rule under TSA's medication policy — but that exemption applies to FDA-approved cannabis pharmaceuticals (Epidiolex, in particular, ships in 100-milliliter pharmacy bottles), not to state-licensed medical cannabis tinctures, which TSA does not treat as prescription medication for the liquid-rule exemption.
The Schedule III rescheduling does not change Customs and Border Protection's posture at U.S. ports of entry. CBP continues to enforce the Controlled Substances Act at the border, treats both Schedule I marijuana and Farm Bill–compliant hemp as substances of interest, and has historically denied entry, issued lifetime bans, and seized product from travelers attempting to cross with cannabis in any form. International travel with any cannabis product — including a state medical card — remains an unforced-error category.
It does not change the Federal Aviation Administration's drug-testing rules for flight crew, ground crew with safety-sensitive functions, or air traffic controllers. It does not change federal workplace drug-testing rules for federal employees, contractors, or any other DOT-regulated employee population. A patient who flies as a passenger with a Schedule III medical cannabis product can be a Schedule III patient on Monday and a fired pilot on Tuesday if she has a positive drug test in the interim.
It does not change international agreements. The 1961 Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances continue to classify cannabis in ways that constrain international air travel even between two countries that have domestically legalized. Puerto Rico, despite being U.S. territory with a medical program, is a particular trap because the flight is domestic but the destination program does not recognize most mainland medical cards.
Three dates are doing all the work in the back half of 2026. The first is June 29, when the DEA hearing on broader rescheduling — the question of whether adult-use cannabis joins medical in Schedule III — begins at the agency's Arlington facility. Notice of intent to participate closed May 28. The hearing is scheduled to conclude by July 15. A favorable outcome would, after a federal rulemaking lag, move the TSA picture significantly further. An unfavorable outcome leaves the current two-tier split in place indefinitely. Our Trump rescheduling executive order operational readiness piece covers the witness landscape and procedural footing.
The second is November 12, when the H.R. 5371 §781 hemp redefinition takes effect and most current hemp-derived cannabinoid products lose their federal legal status. Travelers should treat the fall as a moving target.
The third is the slower, longer process: FDA guidance on whether and how the agency intends to assert authority over state-licensed medical cannabis as a Schedule III drug category. Treasury and FinCEN guidance on whether banks can finally serve medical cannabis operators without filing Suspicious Activity Reports. State medical-program rule updates as states decide whether and how to align with the federal Schedule III treatment to preserve their licensees' tax-and-banking benefits.
For the air-traveler reader, the practical takeaway has not really moved in two months: travel with as little cannabis-adjacent product as you can; if you must travel with any, bring Farm Bill–compliant hemp in original packaging with a current COA; if you must travel with state-licensed medical, bring the card, the dispensary packaging, the receipt, and a low expectation of how much that will help if you land in a prohibitionist state.
The line between a federal Schedule III medical cannabis patient traveling in compliance with both source-state and destination-state law and a possessor of a controlled substance in violation of state criminal code is, at most U.S. airports, walked by a single airport police officer in a single conversation. Travelers who land on the wrong side of that line need state-law-specific representation, not a federal-policy explainer. Our Cannabis Lawyer Directory indexes attorneys by state.
This guide is editorial and does not constitute legal advice. State and federal cannabis law moves quickly; verify any specific question with counsel admitted in the relevant jurisdiction.
Last updated: May 23, 2026 · By Compliance Carl, Senior Compliance Editor
On April 27, 2026 — one day before the federal Schedule III rescheduling of state-licensed medical marijuana took effect — the Transportation Security Administration quietly updated its Medical Marijuana page on the What Can I Bring? tool. The carry-on and checked-bag entries now read Yes (Special Instructions). The page's old paragraphs declaring marijuana federally illegal are gone. The standing officer instruction now refers to illegal drugs rather than marijuana or other illegal drugs.
The page does not, anywhere, explain what the special instructions are. There is no quantity limit. There is no documentation requirement. There is no list of qualifying states or product types. As of this writing, the page sits there with a green Yes and a label that links to nothing.
That is the news, and it is most of what travelers actually need to understand. The rest — what counts as compliant, what an Atlanta airport police officer will do when she sees a vape pen in your bag, whether your hemp seltzer is about to be reclassified out of existence on November 12 — is the part this guide is here to cover.
The textual change to the TSA page is real, and the timing is not a coincidence. Acting Attorney General Todd Blanche signed the DOJ rescheduling order on April 22, 2026; the DEA's corresponding Federal Register notice published on April 28; the TSA page update landed in between. DOJ's announcement describes the change as placing two specific categories — FDA-approved drug products containing marijuana, and marijuana subject to a qualifying state-issued medical license — in Schedule III. Everything else stays in Schedule I.
What did not change, and the part that is getting badly misreported, is TSA's actual enforcement posture. A TSA spokesperson told Snopes in early May that the agency's policy on medical marijuana has not changed, and that the screening protocol — which has technically permitted medical cannabis meeting federal requirements since 2019 — is the same protocol that was in force the week before the April rescheduling. GBH News reported on May 19, 2026 that the union representing New England TSA workers had not been briefed on the policy implications of the change as of mid-May. Frontline screeners are reading the website like everyone else.
The honest summary: a piece of TSA website copy now matches a piece of federal scheduling law. What that means in operational terms, at any given checkpoint on any given day, is up to the screener and to the local airport police who get called if cannabis is found.
The April rescheduling moves only two things to Schedule III. Everything outside those two categories is still Schedule I, and for air travel that distinction is the whole game.
The first category is FDA-approved cannabis-derived pharmaceuticals. The four currently approved are Epidiolex (cannabidiol oral solution, approved for refractory pediatric epilepsy and tuberous sclerosis complex), Marinol and Syndros (synthetic dronabinol), and Cesamet (nabilone). These have always been the cleanest air-travel scenario for any cannabis-derived product: they ship in original pharmacy packaging with a prescription label and your name on it, and TSA's general medication carry-on guidance applies. The rescheduling does not change how they are handled at the checkpoint — but it does mean that if a screener pulls one out of your bag and asks, the answer is now Schedule III prescription rather than Schedule III prescription that contains a Schedule I substance, which was the awkward prior framing.
The second category is the more consequential one. Marijuana that is manufactured, distributed, or dispensed under a qualifying state-issued license, for medical purposes only, is now Schedule III. The phrase for medical purposes only is doing real structural work in the order. A state license that authorizes both medical and adult-use activity does not, on the face of the order, qualify the medical activity for Schedule III. DEA has signaled it will look at operational separation — segregated inventory, separate registration, customer-facing program — not the paper of the license alone.
What this means for a traveler: a Florida medical marijuana patient with a state card and a state-licensed product is, post-April 28, carrying a Schedule III product through the checkpoint. A New Jersey adult-use customer with a recreationally purchased product is still carrying a Schedule I product, even though the flower may have come from the same building. The TSA page's green Yes applies to the first traveler and not to the second. For the deeper operator-side picture on this split, see our two-tier federal cannabis market explainer.
The largest single category of cannabis-adjacent product that travelers actually carry through TSA in 2026 is not marijuana flower. It is hemp-derived CBD oils, tinctures, and Delta-9 THC beverages — the Cann, Wynk, Nowadays, and BRĒZ category — sold over the counter at gas stations and grocery stores in states that allow them.
Through November 11, 2026, these products are governed by the 2018 Farm Bill's hemp definition: cannabis with no more than 0.3 percent Delta-9 THC by dry weight. A standard 12-ounce Cann clears that threshold because the calculation is by dry weight of the source cannabis, not by Delta-9 milligrams per finished serving. TSA's screening posture on Farm Bill–compliant hemp products is essentially nonexistent — agents do not screen for it, are not equipped to test for THC percentage on the spot, and have no protocol that singles out hemp drinks from any other beverage. The only TSA-level issue is the standard 3.4-ounce liquid rule for carry-on, which is what catches most hemp beverage travelers. Larger containers go in checked bags or get left behind.
If you are flying with a hemp Delta-9 drink in 2026, the practical risk is not TSA. It is destination-state and airport-of-arrival law. We have covered the brand-specific picture and current state filters in detail in our 2026 THC drinks guide.
The hemp-product picture changes hard on November 12, 2026. That is the effective date of Section 781 of H.R. 5371, the November 2025 continuing resolution that quietly rewrote the federal hemp definition. Arnold & Porter's December 2025 analysis walks through the mechanics.
The new federal definition replaces the 0.3-percent-Delta-9-by-dry-weight test with a 0.4-milligram-total-THC-per-container cap. Total THC includes Delta-9, THCA, and any other cannabinoid the Secretary of HHS designates as having similar effects. Most existing hemp gummy and beverage formulations — which routinely contain 2 to 10 milligrams of Delta-9 per serving and 10 to 50 milligrams per container — fall on the wrong side of the new line. Industry groups estimate roughly 95 percent of current hemp-derived cannabinoid products will be federally non-compliant on the morning of November 12.
For a traveler in mid-November, the question of whether a hemp seltzer is federally legal will turn on the per-container milligram math, not the dry-weight percentage. Products purchased before the effective date do not become contraband retroactively, but they are also not protected by some grandfather clause, and the carrier and airport-police posture on November 13 is anyone's guess. The smart move for anyone flying with hemp beverages or edibles in the fall of 2026 is to assume the rules tighten and to leave anything you would not want confiscated at home. Operators making forward decisions on shipping and inventory should see our 2026 carrier-policy tightening analysis.
For Farm Bill–compliant hemp products, the documentation that most matters is the product's Certificate of Analysis. Carry the batch-specific COA — paper or phone — that matches the lot number on the label. The COA should clearly show Delta-9 THC at or below 0.3 percent by dry weight and identify hemp as the source. TSA agents do not read COAs as a matter of course, but airport police called in to evaluate a product often will, and a clean COA on the spot dramatically shortens the conversation.
For state-licensed medical cannabis post-April 28, the documentation that matters is your state medical card paired with state-licensed product packaging. The product should be in its original child-resistant dispensary container with the dispensary label, batch identifier, and patient name intact. A dispensary receipt with the patient name is a useful add-on. None of this is required by TSA — TSA does not gate-check medical cards — but airport police in states that recognize the rescheduling will look at exactly these documents when they decide whether to call it federally compliant or not.
Original packaging is not a polite suggestion. Removing edibles from dispensary packaging to put them in a pill organizer or a sandwich bag converts a compliant Schedule III product into an unknown brown substance, and the screener has no way to distinguish the two. Same with tinctures decanted into travel bottles. Same with flower in a smell-proof pouch.
The TSA page change does not preempt state law. State and local police enforce the state criminal code at the airport, and a federal Schedule III designation does not create a federal preemption that protects a traveler from arrest under, say, the Georgia Controlled Substances Act. The April rescheduling did not change the calculus on the state side at all.
In broad strokes, the airport-by-airport picture in 2026 looks like this. Los Angeles International (LAX) operates under a written Los Angeles Airport Police Division policy that does not arrest adults 21 and over carrying compliant amounts of cannabis through screening; the policy long predates the rescheduling. San Francisco, Oakland, Seattle-Tacoma, Denver (with a quirk — DEN has its own airport-specific cannabis ban inside terminal property, separate from Colorado state law), Las Vegas, Phoenix, Boston, Chicago O'Hare and Midway (the Chicago airports have amnesty boxes at security), New York LGA and JFK, and Portland behave broadly the way LAX does: not actively looking, not arresting compliant adults.
The other side of the map is the part to take seriously. Atlanta-Hartsfield, Dallas-Fort Worth, Houston Intercontinental, Miami International, Orlando, Charlotte-Douglas, Nashville, Birmingham, Jackson (Mississippi), Oklahoma City, and Memphis route cannabis discoveries to airport police, and those airport police operate under state codes that treat possession as a criminal offense regardless of how the traveler obtained the product. A New Jersey patient with a state card and a New Jersey-compliant THCA product who lands in Atlanta has, on landing, the same legal status as anyone else in Georgia carrying cannabis. The patient card does not travel.
The federal medical-marijuana program does not, despite years of legislative attempts, include any out-of-state patient reciprocity for transport. A handful of state programs allow visiting patients to purchase locally on a temporary card. None of them allows a visiting patient to bring product across the state line.
Hemp and cannabis vapes are governed by FAA hazardous materials rules, not TSA cannabis posture. The FAA's PackSafe entry on e-cigarettes requires that all vape devices and spare lithium batteries travel in carry-on, never checked, with batteries protected from short-circuit (in the device, in a case, or with the terminals taped). The cannabinoid content is downstream of the battery question; the battery question is what gets a checked bag pulled. Hemp vape shipping has its own separate world — the PACT Act effectively bans direct-to-consumer hemp vape shipping by USPS, UPS, FedEx, and DHL, which we have covered in our PACT Act hemp vape analysis.
Edibles — gummies, chocolates, brownies, mints — are solids and do not trigger the liquid rule. The TSA-level posture on hemp-derived edibles is, like beverages, essentially nonexistent through November 11. After November 12, the milligram math determines federal status. We break down the form-by-form picture in the edibles-on-a-plane guide.
Tinctures and oils are liquids and are bound by the 3.4-ounce / 100-milliliter carry-on limit. A 1-ounce CBD dropper bottle is fine in carry-on; a 4-ounce bottle is not, regardless of cannabinoid content. Pharmacy-labeled prescription liquids in excess of 3.4 ounces are exempt from the liquid rule under TSA's medication policy — but that exemption applies to FDA-approved cannabis pharmaceuticals (Epidiolex, in particular, ships in 100-milliliter pharmacy bottles), not to state-licensed medical cannabis tinctures, which TSA does not treat as prescription medication for the liquid-rule exemption.
The Schedule III rescheduling does not change Customs and Border Protection's posture at U.S. ports of entry. CBP continues to enforce the Controlled Substances Act at the border, treats both Schedule I marijuana and Farm Bill–compliant hemp as substances of interest, and has historically denied entry, issued lifetime bans, and seized product from travelers attempting to cross with cannabis in any form. International travel with any cannabis product — including a state medical card — remains an unforced-error category.
It does not change the Federal Aviation Administration's drug-testing rules for flight crew, ground crew with safety-sensitive functions, or air traffic controllers. It does not change federal workplace drug-testing rules for federal employees, contractors, or any other DOT-regulated employee population. A patient who flies as a passenger with a Schedule III medical cannabis product can be a Schedule III patient on Monday and a fired pilot on Tuesday if she has a positive drug test in the interim.
It does not change international agreements. The 1961 Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances continue to classify cannabis in ways that constrain international air travel even between two countries that have domestically legalized. Puerto Rico, despite being U.S. territory with a medical program, is a particular trap because the flight is domestic but the destination program does not recognize most mainland medical cards.
Three dates are doing all the work in the back half of 2026. The first is June 29, when the DEA hearing on broader rescheduling — the question of whether adult-use cannabis joins medical in Schedule III — begins at the agency's Arlington facility. Notice of intent to participate closed May 28. The hearing is scheduled to conclude by July 15. A favorable outcome would, after a federal rulemaking lag, move the TSA picture significantly further. An unfavorable outcome leaves the current two-tier split in place indefinitely. Our Trump rescheduling executive order operational readiness piece covers the witness landscape and procedural footing.
The second is November 12, when the H.R. 5371 §781 hemp redefinition takes effect and most current hemp-derived cannabinoid products lose their federal legal status. Travelers should treat the fall as a moving target.
The third is the slower, longer process: FDA guidance on whether and how the agency intends to assert authority over state-licensed medical cannabis as a Schedule III drug category. Treasury and FinCEN guidance on whether banks can finally serve medical cannabis operators without filing Suspicious Activity Reports. State medical-program rule updates as states decide whether and how to align with the federal Schedule III treatment to preserve their licensees' tax-and-banking benefits.
For the air-traveler reader, the practical takeaway has not really moved in two months: travel with as little cannabis-adjacent product as you can; if you must travel with any, bring Farm Bill–compliant hemp in original packaging with a current COA; if you must travel with state-licensed medical, bring the card, the dispensary packaging, the receipt, and a low expectation of how much that will help if you land in a prohibitionist state.
The line between a federal Schedule III medical cannabis patient traveling in compliance with both source-state and destination-state law and a possessor of a controlled substance in violation of state criminal code is, at most U.S. airports, walked by a single airport police officer in a single conversation. Travelers who land on the wrong side of that line need state-law-specific representation, not a federal-policy explainer. Our Cannabis Lawyer Directory indexes attorneys by state.
This guide is editorial and does not constitute legal advice. State and federal cannabis law moves quickly; verify any specific question with counsel admitted in the relevant jurisdiction.
